Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2230308 Title: Molécules d'anticorps dotées d'une spécificité pour le facteur alpha humain de nécrose de tumeur et leurs utilisations

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
091762518
WO application number:
Type:
European patent granted for BE
Status:
Expired
Publication number:
2230308
WO publication number:
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:

Dates

Filing date:
05/06/2001
Grant date:
23/01/2013
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
18/04/2013
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
23/01/2013
EP B1 publication date:
23/01/2013
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
05/06/2021

Applicant

Name:
UCB Pharma S.A.
Legal Form:
From:
23/01/2013
Address:
Intellectual Property Department Allée de la Recherche 60, 1070, Brussels, Belgium (BE)
To:

Agent

Name:
NORRIS Allen
Legal Form:
From:
18/04/2013
Address:
Allée de la Recherche 60, 1070, BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
Athwal, Diljeet Singh
Legal Form:
Address:

2

Name:
Brown, Derek Thomas
Legal Form:
Address:

3

Name:
Weir, Andrew Neil Charles
Legal Form:
Address:

4

Name:
Popplewell, Andrew George
Legal Form:
Address:

5

Name:
Chapman, Andrew Paul
Legal Form:
Address:

6

Name:
King, David John
Legal Form:
Address:

Priority

Priority patent number:
0013810
Priority date:
06/06/2000
Priority country:
United Kingdom (GB)

Classification

Main IPC class:
C12N 15/13;
IPC or IDT classification:
A61K 39/395; A61K 47/48; A61P 19/02; A61P 37/06; C07K 16/24; C07K 16/46; C07K 19/00; C12N 1/21; C12N 15/62; C12N 15/70;

Publication

Bulletin

1

Bulletin heading:
EP3
Journal edition number:
2013/04
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

2

Bulletin heading:
VRV
Journal edition number:
2021/11
Publication date:
15/07/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
15/05/2020
Last annual fee paid number:
20
Last annual fee paid amount:
600 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
18/04/2013 General Document (TP - T:Traduction Originale plus Pouvoir) 134 PDF /8/0/3/0/3/0512230308/migrated-docs/091762518_1_307268.pdf